NEW YORK (Reuters) - Shares of Wyeth rose 5.2 percent to $46.00 before the opening bell on Monday after rival Pfizer said it would buy the company for about $68 billion.
The news sent shares of PFIZER (PFE.NY) the No. 1 drugmaker, down 3.3 percent at $16.87.
(Reporting by Leah Schnurr; Editing by Theodore d'Afflisio)
